{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:51:34Z","timestamp":1745931094258},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"DOI":"10.1007\/s11356-023-25527-2","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T06:02:45Z","timestamp":1675490565000},"page":"47381-47393","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and Bangladesh"],"prefix":"10.1007","volume":"30","author":[{"given":"Arifa","family":"Sultana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabiha Rahman","family":"Mim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahmida","family":"Yesmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Rafat","family":"Tahsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasiba Binte","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazi Rubiya","family":"Fatema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saimon","family":"Shahriar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazi Milenur Rahman","family":"Prattay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazle","family":"Rabbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiha","family":"Noushin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithun","family":"Samodder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qurratul Ain","family":"Sadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Ariful Haque","family":"Mamun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ikram","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahmina","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Mustafizur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Moklesur Rahman","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Ruhul","family":"Kuddus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahima","family":"Aktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakir Ahmed","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Asad","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaila","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan Mehtap","family":"B\u00fcy\u00fcker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Sohanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Habibur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Shah","family":"Amran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"issue":"4","key":"25527_CR1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250495","volume":"16","author":"M Abedin","year":"2021","unstructured":"Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Hossain MA, Arefin A, Hossain A (2021) Willingness to vaccinate against COVID-19 among Bangladeshi adults: understanding the strategies to optimize vaccination coverage. PLoS ONE 16(4):e0250495","journal-title":"PLoS ONE"},{"issue":"6","key":"25527_CR2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/vaccines9060674","volume":"9","author":"A Alhazmi","year":"2021","unstructured":"Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, Maghfuri A, Algaissi A (2021) Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines 9(6):674","journal-title":"Vaccines"},{"key":"25527_CR3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fpubh.2020.00188","volume":"8","author":"AB Al-Tammemi","year":"2020","unstructured":"Al-Tammemi AB (2020) The battle against COVID-19 in Jordan: an early overview of the Jordanian experience. Front Public Health 8:188","journal-title":"Front Public Health"},{"issue":"4","key":"25527_CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/radm.12455","volume":"51","author":"L Ardito","year":"2021","unstructured":"Ardito L, Coccia M, Messeni Petruzzelli A (2021) Technological exaptation and crisis management: evidence from COVID-19 outbreaks. R&d Management 51(4):381\u2013392","journal-title":"R&d Management"},{"issue":"10","key":"25527_CR5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/annrheumdis-2021-220503","volume":"80","author":"Y Braun-Moscovici","year":"2021","unstructured":"Braun-Moscovici Y, Kaplan M, Braun M, Markovits D, Giryes S, Toledano K, Tavor Y, Dolnikov K, Balbir-Gurman A (2021) Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2. Ann Rheum Dis 80(10):1317\u20131321","journal-title":"Ann Rheum Dis"},{"issue":"7871","key":"25527_CR6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/d41586-021-02158-6","volume":"596","author":"E Callaway","year":"2021","unstructured":"Callaway E (2021) COVID vaccine boosters: the most important questions. Nature 596(7871):178\u2013180","journal-title":"Nature"},{"key":"25527_CR7","unstructured":"CDC (2022) Understanding how COVID-19 vaccines work. Centers for Disease Control and Prevention. Last accessed: 25 January, 2022. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/how-they-work.html"},{"issue":"11","key":"25527_CR8","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/vaccines10111943","volume":"10","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Vihol DR, Solanki HK, Apostolopoulos V (2022) The vaccine world of COVID-19: India\u2019s Contribution. Vaccines 10(11):1943","journal-title":"Vaccines"},{"key":"25527_CR9","doi-asserted-by":"crossref","unstructured":"Coccia M (2021) Preparedness of countries to face COVID-19 pandemic crisis: strategic positioning and underlying structural factors to support strategies of prevention of pandemic threats. Environ Res 111678","DOI":"10.1016\/j.envres.2021.111678"},{"key":"25527_CR10","doi-asserted-by":"crossref","unstructured":"Cohen J (2021) What went wrong with CureVac\u2019s mRNA vaccine? American Association for the Advancement of Science. Available at: https:\/\/www.science.org\/content\/article\/what-went-wrong-curevac-s-highly-anticipated-new-mrna-vaccine-covid-19","DOI":"10.1126\/science.372.6549.1381"},{"issue":"7878","key":"25527_CR11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/d41586-021-02532-4","volume":"597","author":"E Dolgin","year":"2021","unstructured":"Dolgin E (2021) COVID vaccine immunity is waning-how much does that matter. Nature 597(7878):606\u2013607","journal-title":"Nature"},{"key":"25527_CR12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, Alghamdi BS, Alahmadi AA, Hassan NA, Sindi N (2021) Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. International Journal of General Medicine 14:1389","journal-title":"International Journal of General Medicine"},{"issue":"1","key":"25527_CR13","first-page":"1","volume":"7","author":"M Fansher","year":"2022","unstructured":"Fansher M, Adkins TJ, Lalwani P, Boduroglu A, Carlson M, Quirk M, Lewis RL, Shah P, Zhang H, Jonides J (2022) Icon arrays reduce concern over COVID-19 vaccine side effects: a randomized control study. Cognitive Research: Principles and Implications 7(1):1\u20139","journal-title":"Cognitive Research: Principles and Implications"},{"key":"25527_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108448","volume":"215","author":"S Felsenstein","year":"2020","unstructured":"Felsenstein S, Herbert JA, McNamara PS, Hedrich CM (2020) COVID-19: immunology and treatment options. Clin Immunol 215:108448","journal-title":"Clin Immunol"},{"issue":"17\u201318","key":"25527_CR15","first-page":"238","volume":"140","author":"PJ Fritsche","year":"2010","unstructured":"Fritsche PJ, Helbling A, Ballmer-Weber BK (2010) Vaccine hypersensitivity-update and overview. Swiss Med Wkly 140(17\u201318):238\u2013246","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"25527_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","volume":"70","author":"J Gee","year":"2021","unstructured":"Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, Nair N, Martin S, Clark T, Markowitz L (2021) First month of COVID-19 vaccine safety monitoring\u2014United States, December 14, 2020\u2013January 13, 2021. Morb Mortal Wkly Rep 70(8):283","journal-title":"Morb Mortal Wkly Rep"},{"issue":"18","key":"25527_CR17","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2102535","volume":"384","author":"E Goralnick","year":"2021","unstructured":"Goralnick E, Kaufmann C, Gawande AA (2021) Mass-vaccination sites\u2014an essential innovation to curb the COVID-19 pandemic. N Engl J Med 384(18):e67","journal-title":"N Engl J Med"},{"key":"25527_CR18","first-page":"169","volume":"1","author":"N Harmukh","year":"2020","unstructured":"Harmukh N (2020) Medicinal plants and their uses in natural immunity improvement with special reference to COVID-19. Research Interventions and Advancements in Plant Sciences 1:169\u2013174","journal-title":"Research Interventions and Advancements in Plant Sciences"},{"issue":"4","key":"25527_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10654-020-00634-3","volume":"35","author":"EA Harrison","year":"2020","unstructured":"Harrison EA, Wu JW (2020) Vaccine confidence in the time of COVID-19. Eur J Epidemiol 35(4):325\u2013330","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"25527_CR20","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1164\/rccm.2021C2","volume":"203","author":"TV Hartert","year":"2021","unstructured":"Hartert TV, Sockrider M (2021) What are COVID-19 vaccines? Am J Respir Crit Care Med 203(9):P22\u2013P23","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"25527_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/vaccines9060556","volume":"9","author":"MM Hatmal","year":"2021","unstructured":"Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R (2021) Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines 9(6):556","journal-title":"Vaccines"},{"issue":"3","key":"25527_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.13005\/bpj\/1733","volume":"12","author":"MA Hossain","year":"2019","unstructured":"Hossain MA, Amran MS (2019) A Cross-Sectional Pilot Study on Pharmacovigilance to Improve the Drug Safety in Bangladesh. Biomedical and Pharmacology Journal 12(3):1039\u20131049","journal-title":"Biomedical and Pharmacology Journal"},{"issue":"11","key":"25527_CR23","doi-asserted-by":"crossref","first-page":"563478","DOI":"10.3389\/fphar.2020.563478","volume":"11","author":"MF Hossain","year":"2020","unstructured":"Hossain MF, Hasana S, al Mamun A, Uddin MS, Wahed MII, Sarker S, Behl T, Ullah I, Begum Y, Bulbul IJ (2020) COVID-19 outbreak: pathogenesis, current therapies, and potentials for future management. Front Pharmacol 11(11):563478","journal-title":"Front Pharmacol"},{"key":"25527_CR24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","volume":"106","author":"RAK Kadali","year":"2021","unstructured":"Kadali RAK, Janagama R, Peruru S, Malayala S, v. (2021) Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis 106:376\u2013381","journal-title":"Int J Infect Dis"},{"issue":"2","key":"25527_CR25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4269\/ajtmh.20-0654","volume":"103","author":"YH Khan","year":"2020","unstructured":"Khan YH, Mallhi TH, Alotaibi NH, Alzarea AI, Alanazi AS, Tanveer N, Hashmi FK (2020) Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives. Am J Trop Med Hyg 103(2):603","journal-title":"Am J Trop Med Hyg"},{"key":"25527_CR26","unstructured":"Khatun F (2021) An impressive start to COVID vaccination in Bangladesh. Daily Star. Available at: https:\/\/www.thedailystar.net\/opinion\/macro-mirror\/news\/impressive-start-covid-vaccination-bangladesh-2044789"},{"issue":"3","key":"25527_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/vaccines9030221","volume":"9","author":"NG Kounis","year":"2021","unstructured":"Kounis NG, Koniari I, de Gregorio C, Velissaris D, Petalas K, Brinia A, Assimakopoulos SF, Gogos C, Kouni SN, Kounis GN (2021) Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines 9(3):221","journal-title":"Vaccines"},{"issue":"14","key":"25527_CR28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","volume":"384","author":"F Krammer","year":"2021","unstructured":"Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF, Berm\u00fadez-Gonz\u00e1lez MC, Bielak DA, Carre\u00f1o JM, Chernet RL (2021) Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med 384(14):1372\u20131374","journal-title":"N Engl J Med"},{"issue":"3","key":"25527_CR29","volume":"55","author":"C-C Lai","year":"2020","unstructured":"Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924","journal-title":"Int J Antimicrob Agents"},{"key":"25527_CR30","doi-asserted-by":"crossref","unstructured":"Lee GM (2021) The importance of context in COVID-19 vaccine safety. In New England Journal of Medicine (Vol. 385, Issue 12, pp. 1138\u20131140). Mass Medical Soc","DOI":"10.1056\/NEJMe2112543"},{"key":"25527_CR31","doi-asserted-by":"crossref","unstructured":"Mahase E (2021) Covid-19: US suspends Johnson and Johnson vaccine rollout over blood clots. BMJ 2021, 373:n970. Available at: https:\/\/www.bmj.com\/content\/373\/bmj.n970","DOI":"10.1136\/bmj.n970"},{"key":"25527_CR32","doi-asserted-by":"crossref","unstructured":"Mallapaty S, Ledford H (2020) COVID-vaccine results are on the way-and scientists\u2019 concerns are growing. Nature 16\u201317","DOI":"10.1038\/d41586-020-02706-6"},{"key":"25527_CR33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.idm.2021.08.008","volume":"6","author":"M Mancuso","year":"2021","unstructured":"Mancuso M, Eikenberry SE, Gumel AB (2021) Will vaccine-derived protective immunity curtail COVID-19 variants in the US? Infectious Disease Modelling 6:1110\u20131134","journal-title":"Infectious Disease Modelling"},{"key":"25527_CR34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21:939\u2013949","journal-title":"Lancet Infect Dis"},{"key":"25527_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdcr.2021.02.018","volume":"10","author":"GG Munavalli","year":"2021","unstructured":"Munavalli GG, Knutsen-Larson S, Lupo MP, Geronemus RG (2021) Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II\u2013induced cutaneous inflammation. JAAD Case Reports 10:63\u201368","journal-title":"JAAD Case Reports"},{"issue":"10","key":"25527_CR36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamacardio.2021.2853","volume":"6","author":"AM Navar","year":"2021","unstructured":"Navar AM, McNally E, Yancy CW, O\u2019Gara PT, Bonow RO (2021) Temporal associations between immunization with the COVID-19 mRNA vaccines and myocarditis: the vaccine safety surveillance system is working. JAMA Cardiology 6(10):1117\u20131118","journal-title":"JAMA Cardiology"},{"key":"25527_CR37","doi-asserted-by":"crossref","unstructured":"Paterlini M (2021) Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people \u201cas a precaution\u201d. BMJ 2021, 375:n2477. Available at: https:\/\/www.bmj.com\/content\/375\/bmj.n2477","DOI":"10.1136\/bmj.n2477"},{"issue":"1","key":"25527_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12903-022-02124-2","volume":"22","author":"M Petruzzi","year":"2022","unstructured":"Petruzzi M, Galleggiante S, Messina S, della Vella, F. (2022) Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases. BMC Oral Health 22(1):1\u20138","journal-title":"BMC Oral Health"},{"issue":"7","key":"25527_CR39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M (2021) Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med 10(7):1428","journal-title":"J Clin Med"},{"key":"25527_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijwd.2021.01.007","volume":"7","author":"SM Rice","year":"2021","unstructured":"Rice SM, Ferree SD, Mesinkovska NA, Kourosh AS (2021) The art of prevention: COVID-19 vaccine preparedness for the dermatologist. International Journal of Women\u2019s Dermatology 7:209\u2013212","journal-title":"International Journal of Women\u2019s Dermatology"},{"key":"25527_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","volume":"111","author":"BQ Saeed","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO (2021) Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis 111:219\u2013226","journal-title":"Int J Infect Dis"},{"issue":"2","key":"25527_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines9020160","volume":"9","author":"M Sallam","year":"2021","unstructured":"Sallam M (2021) COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines 9(2):160","journal-title":"Vaccines"},{"issue":"1","key":"25527_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/vaccines9010042","volume":"9","author":"M Sallam","year":"2021","unstructured":"Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A (2021) High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines 9(1):42","journal-title":"Vaccines"},{"issue":"3","key":"25527_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4155\/tde-2020-0129","volume":"12","author":"SH Shahcheraghi","year":"2021","unstructured":"Shahcheraghi SH, Ayatollahi J, Aljabali AAA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M (2021) An overview of vaccine development for COVID-19. Ther Deliv 12(3):235\u2013244","journal-title":"Ther Deliv"},{"key":"25527_CR45","first-page":"2413","volume":"11","author":"O Sharma","year":"2020","unstructured":"Sharma O, Sultan AA, Ding H, Triggle CR (2020) A review of the progress and challenges of developing a vaccine for COVID-19. Front Immunol 11:2413","journal-title":"Front Immunol"},{"issue":"8","key":"25527_CR46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.2021.0600","volume":"325","author":"T Shimabukuro","year":"2021","unstructured":"Shimabukuro T, Nair N (2021) Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA 325(8):780\u2013781","journal-title":"JAMA"},{"key":"25527_CR47","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2147\/JMDH.S331140","volume":"14","author":"Y Solomon","year":"2021","unstructured":"Solomon Y, Eshete T, Mekasha B, Assefa W (2021) COVID-19 vaccine: side effects after the first dose of the Oxford AstraZeneca vaccine among health professionals in low-income country: Ethiopia. J Multidiscip Healthc 14:2577","journal-title":"J Multidiscip Healthc"},{"issue":"10","key":"25527_CR48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/vaccines9101090","volume":"9","author":"A Sultana","year":"2021","unstructured":"Sultana A, Shahriar S, Tahsin M, Mim SR, Fatema KR, Saha A, Yesmin F, Bahar NB, Samodder M, Mamun M (2021) A retrospective cross-sectional study assessing self-reported adverse events following immunization (AEFI) of the COVID-19 vaccine in Bangladesh. Vaccines 9(10):1090","journal-title":"Vaccines"},{"issue":"1","key":"25527_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99269-x","volume":"12","author":"CLF Sun","year":"2022","unstructured":"Sun CLF, Jaffe E, Levi R (2022) Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Sci Rep 12(1):1\u201312","journal-title":"Sci Rep"},{"issue":"6","key":"25527_CR50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11165-016-9602-2","volume":"48","author":"KS Taber","year":"2018","unstructured":"Taber KS (2018) The use of Cronbach\u2019s alpha when developing and reporting research instruments in science education. Res Sci Educ 48(6):1273\u20131296","journal-title":"Res Sci Educ"},{"key":"25527_CR51","doi-asserted-by":"crossref","unstructured":"Tazerji SS, Shahabinejad F, Tokasi M, Rad MA, Khan MS, Safdar M, Filipiak KJ, Szarpak L, Dzieciatkowski T, Jurgiel J (2022) Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep 101505","DOI":"10.1016\/j.genrep.2022.101505"},{"issue":"36","key":"25527_CR52","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2021.07.047","volume":"39","author":"N Tissot","year":"2021","unstructured":"Tissot N, Brunel A-S, Bozon F, Rosolen B, Chirouze C, Bouiller K (2021) Patients with history of COVID-19 had more side effects after the first dose of COVID-19 vaccine. Vaccine 39(36):5087\u20135090","journal-title":"Vaccine"},{"issue":"4","key":"25527_CR53","first-page":"180","volume":"37","author":"B Toku\u00e7","year":"2020","unstructured":"Toku\u00e7 B, Varol G (2020) Medical education in Turkey in time of COVID-19. Balkan Med J 37(4):180","journal-title":"Balkan Med J"},{"key":"25527_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","volume":"194","author":"G Troiano","year":"2021","unstructured":"Troiano G, Nardi A (2021) Vaccine hesitancy in the era of COVID-19. Public Health 194:245\u2013251","journal-title":"Public Health"},{"issue":"5","key":"25527_CR55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/ijmr.IJMR_957_20","volume":"151","author":"GM Varghese","year":"2020","unstructured":"Varghese GM, John R, Manesh A, Karthik R, Abraham OC (2020) Clinical management of COVID-19. Indian J Med Res 151(5):401","journal-title":"Indian J Med Res"},{"issue":"8","key":"25527_CR56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782\u2013793","journal-title":"JAMA"},{"key":"25527_CR57","doi-asserted-by":"crossref","unstructured":"Wise J (2021) COVID-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ 2021, 372:n699. Available at: https:\/\/www.bmj.com\/content\/372\/bmj.n699","DOI":"10.1136\/bmj.n699"},{"issue":"1","key":"25527_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01826-0","volume":"19","author":"Q Wu","year":"2021","unstructured":"Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, Salmon D, Yu H (2021) Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med 19(1):1\u201316","journal-title":"BMC Med"},{"issue":"10240","key":"25527_CR59","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"FC Zhu","year":"2020","unstructured":"Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L (2020) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet 395(10240):1845\u20131854","journal-title":"The Lancet"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-023-25527-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-023-25527-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-023-25527-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T09:05:11Z","timestamp":1681290311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-023-25527-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":59,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["25527"],"URL":"https:\/\/doi.org\/10.1007\/s11356-023-25527-2","relation":{},"ISSN":["1614-7499"],"issn-type":[{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Ethical Review Committee of the Faculty of Biological Sciences, University of Dhaka (Ref. No. 159\/Biol. Scs.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants gave their implied consent to participate in the study by voluntarily completing the survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed in this article are the personal views of the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}